Isolation and antigenic characterization of human immunodeficiency virus (HIV) in Brazil. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Isolation and antigenic characterization of human immunodeficiency virus (HIV) in Brazil.

Mem Inst Oswaldo Cruz. 1987 Oct-Dec;82(4):453-6. Unique Identifier : AIDSLINE MED/89200855
Galvao-Castro B; Ivo-Dos-Santos J; Couto-Fernandez JC; Bongertz V; Chequer-Bou-Habib D; Sion FS; Barth OM; Pereira H; Pereira MS; Instituto Oswaldo Cruz, Rio de Janeiro, Brasil.


Abstract: A retrovirus infecting a Brazilian AIDS patient was isolated and characterized in terms of its reactivity with sera from individuals infected with human immunodeficiency viruses 1 and 2 (HIV-1 and HIV-2). The Western blot analysis revealed that the Brazilian isolate is very similar to the well characterized HIV-1 strain. The serum of the patient from whom the virus was isolated did not react with the 140 kDa envelope glycoprotein specific for HIV-2.
Keywords: Adult Blotting, Western Brazil Case Report Enzyme-Linked Immunosorbent Assay Human HIV Antibodies/IMMUNOLOGY HIV Antigens/*ANALYSIS HIV-1/IMMUNOLOGY/*ISOLATION & PURIF HIV-2/IMMUNOLOGY Male JOURNAL ARTICLE

KWDadultblotting,westernbrazilcasereportenzyme-linkedimmunosorbentassayhumanhivantibodies/immunologyhivantigens/KWDanalysishiv-1/immunology/KWDisolation&purifhiv-2/immunologymalejournalarticle
890730
M8970782


Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .